Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-EN Version v4-FR
Language English French
Date Updated 2023-02-17 2023-02-03
Drug Identification Number 02341220 02341220
Brand name BUTRANS 20 BUTRANS 20
Common or Proper name Buprenorphine Transdermal System Buprenorphine Transdermal System
Company Name PURDUE PHARMA PURDUE PHARMA
Ingredients BUPRENORPHINE BUPRENORPHINE
Strength(s) 20MCG 20MCG
Dosage form(s) PATCH PATCH
Route of administration TRANSDERMAL TRANSDERMAL TRANSDERMAL TRANSDERMAL
Packaging size 4 4
ATC code N02AE N02AE
ATC description OPIOIDS OPIOIDS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2023-02-03 2023-02-03
Actual start date 2023-02-03 2023-02-03
Estimated end date 2023-03-31 2023-03-10
Actual end date 2023-02-16
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments